Aryzta AG
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ARZTY research report →
Price Chart
About the company
Based in Schlieren, Switzerland, ARYZTA AG, established in 1897, operates as a leading supplier of frozen bakery solutions for business-to-business clients. Its operations span Europe, Asia, Australia, and New Zealand. The company's comprehensive product line includes diverse baked items such as pastries, biscuits, doughnuts, muffins, various buns, artisan breads, sweet morning treats, and a range of savory products.
- CEO
- Urs Jordi
- IPO
- 2011
- Employees
- 7,654
- HQ
- Schlieren, ZH, CH
Get TickerSpark's AI analysis on ARZTY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.24B
- P/E
- 9.84
- PEG
- 3.69
- P/S
- 0.47
- P/B
- 2.31
- EV/EBITDA
- 6.18
- Div Yield
- 0.00%
- Gross Margin
- 31.81%
- Op Margin
- 7.37%
- Net Margin
- 5.02%
- ROE
- 22.06%
- ROIC
- 9.71%
Latest fiscal year · YoY change
- Revenue
- $2.14B-2.7%
- Gross Profit
- $675.16M+43.9%
- Op Income
- $165.69M
- Net Income
- $107.87M-16.8%
- EPS
- $0.41+3990.0%
- OCF Growth
- -17.2%
- FCF Growth
- -19.2%
- 52W High
- $7.80
- 52W Low
- $4.72
- 50D MA
- $5.37
- 200D MA
- $6.67
- Beta
- 0.35
- RSI (14)
- 0
- Avg Volume
- 54
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
ARYZTA reported a softer H1 2026 with negative organic growth and lower margins, but kept full-year profit and cash guidance intact while accelerating cost actions and reviewing options for Germany.· August 10, 2026
- H1 revenue was EUR 1,063.9 million with organic growth of -2.7%; EPS was EUR 1.82 and free cash flow was EUR 23.6 million.
- Reported EBITDA margin was 13.2%, down 70 bps year over year, with about EUR 5.4 million of one-time Excellence Programme costs.
- Germany was the clear weak spot; management said the issue is market and consumer demand, not contract losses or insourcing on its side.
- Project Excellence is rolling out faster, with 45% of production volume already addressed and EUR 8 million-EUR 10 million of gross cost reductions identified and confirmed.
- Management reiterated 2026 guidance for organic growth at the lower end of the range, further EBITDA/EBIT improvement, solid cash generation, and lower net debt to EBITDA, while reviewing Germany and planning 2027 capital returns.
For H1 2026, revenue was EUR 1,063.9 million, organic growth was -2.7%, EBITDA was EUR 139.9 million, EBITDA margin was 13.2%, free cash flow was EUR 23.6 million, and EPS was EUR 1.82. Revenue declined 2.1% reported, with a positive FX impact of 0.6%; EBITDA margin was down 70 bps year over year, and one-time Excellence Programme costs were about EUR 5.4 million, or roughly 50 bps of revenue. Net debt fell by almost EUR 100 million to EUR 789 million, leverage was 2.7x, core equity rose to 23.3% of total assets, and financing costs declined by EUR 5.5 million to EUR 16.8 million. For 2026, management expects organic growth at the lower end of the guidance range, further EBITDA and EBIT improvement, solid cash generation, and an improvement in net debt to EBITDA; full-year financing costs are now guided to the lower end of EUR 37 million-EUR 40 million versus prior EUR 40 million-EUR 43 million.
Urs Jordi said the first half was pressured by heightened macro and geopolitical uncertainty, weaker consumer sentiment, and tough prior-year comps, with Germany being the main drag. He emphasized that the company is pushing Project Excellence faster, streamlining the organization, and considering all options for Germany to maximize shareholder value. He also pointed to a 19% innovation rate as a support for premiumization and said the board plans to propose a capital return framework at the 2027 AGM, potentially via dividends, buybacks, or both.
Martin Huber focused on the financial resilience of the business despite the weaker top line. He cited a 13.2% reported EBITDA margin, 70 bps below last year, with about EUR 5.4 million of one-time costs tied mainly to restructuring and consulting; gross margin before distribution was flat year over year, helped by 90 bps from procurement and savings and 20 bps from innovation. He highlighted disciplined working capital and CapEx, free cash flow of EUR 23.6 million, net debt down to EUR 789 million, leverage at 2.7x, and financing costs improved to EUR 16.8 million, leading to a lowered full-year financing cost outlook of EUR 37 million-EUR 40 million. He also said the group expects Europe margin recovery in the second half and that rest of world EBITDA margin should return to prior-year levels for the full year.
Analysts pressed on whether Germany’s weakness was due to market decline, lost contracts, or insourcing. Management said it was mainly the market and consumer environment, with the German bread market down in value and volume, but later acknowledged that larger customers with their own manufacturing can re-insource when markets are short, reducing addressable volume. Questions also focused on what drives confidence in second-half guidance and growth beyond 2026; management pointed to channel penetration, new facilities such as Perth, continued innovation, lower comps, and the Excellence Programme as the main supports. On Germany, management said the strategic review will conclude sometime in the second half of this year, but did not give more detail on possible factory closures or asset impacts.
Management believes the business is taking control of what it can: cost savings are being realized faster, 45% of the footprint is already covered by Excellence, and EUR 8 million-EUR 10 million of gross cost reductions have been identified. Cash generation remains solid, leverage is falling, financing costs are improving, and management expects a stronger second half helped by innovation, new facilities, and easier comparisons.
The main risk is Germany, where consumer demand is weak and management is reviewing all options, which could imply restructuring or operational changes with uncertain costs and timing. Organic growth was negative in H1, retail and Europe remain challenged, and management said the market is likely to stay difficult, mainly in Europe and retail, even as they target only the lower end of guidance.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 9.4%
- Shares Outstanding
- 262.73M
- Float Shares
- 24.74M
Our ARZTY coverage
Recent articles, reports, and earnings notes.
No research on ARZTY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ARZTY report →ARYZTA AG (ARZTY) Q2 2026 Earnings Call Transcript
seekingalpha.com · Aug 11
ARYZTA AG (ARZTY) Q4 2025 Earnings Call Transcript
seekingalpha.com · Mar 2
ARYZTA AG (ARZTY) Q4 2025 Sales/Trading Call Transcript
seekingalpha.com · Jan 22
Contrasting Sow Good (OTCMKTS:SOWG) & Aryzta (OTCMKTS:ARZTY)
defenseworld.net · Jan 20
ARYZTA AG - Special Call
seekingalpha.com · Oct 8
ARYZTA AG (ARZTF) CEO Urs Jordi on Q4 2021 Results - Earnings Call Transcript
seekingalpha.com · Oct 4
Lindsay Goldberg to Acquire ARYZTA AG's North American Bakery Business
businesswire.com · Mar 12
Elliott Statement on ARYZTA
businesswire.com · Dec 7
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.